<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>FEATURES OF THE TREATMENT OF AUTOIMMUNE THYROID DISEASES IN ADOLESCENT BOYS</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Arabboyev</mods:namePart><mods:namePart type="family">Shoruhbek</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>This study examined clinical features, immunological markers, and hormonal profiles of autoimmune thyroiditis (AIT) in 72 adolescent males aged 12–17 years. Anti-TPO titers (248.6±32.4 IU/mL) and TSH levels (5.8±1.2 mIU/L) were significantly elevated compared to controls (p&amp;lt;0.001). Subclinical hypothyroidism was detected in 43.1% of cases. The findings support the need for broader AIT screening in adolescent males.
&amp;nbsp;</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-06-06</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>